Cargando…
Clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow CFU-GM to adriamycin and VP16.
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
1988
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246452/ https://www.ncbi.nlm.nih.gov/pubmed/3408645 |
| _version_ | 1782150774614130688 |
|---|---|
| author | Smith, M. A. Merry, S. Smith, J. G. Kaye, S. B. |
| author_facet | Smith, M. A. Merry, S. Smith, J. G. Kaye, S. B. |
| author_sort | Smith, M. A. |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2246452 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 1988 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-22464522009-09-10 Clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow CFU-GM to adriamycin and VP16. Smith, M. A. Merry, S. Smith, J. G. Kaye, S. B. Br J Cancer Research Article Nature Publishing Group 1988-06 /pmc/articles/PMC2246452/ /pubmed/3408645 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Research Article Smith, M. A. Merry, S. Smith, J. G. Kaye, S. B. Clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow CFU-GM to adriamycin and VP16. |
| title | Clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow CFU-GM to adriamycin and VP16. |
| title_full | Clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow CFU-GM to adriamycin and VP16. |
| title_fullStr | Clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow CFU-GM to adriamycin and VP16. |
| title_full_unstemmed | Clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow CFU-GM to adriamycin and VP16. |
| title_short | Clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow CFU-GM to adriamycin and VP16. |
| title_sort | clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow cfu-gm to adriamycin and vp16. |
| topic | Research Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246452/ https://www.ncbi.nlm.nih.gov/pubmed/3408645 |
| work_keys_str_mv | AT smithma clinicallyrelevantconcentrationsofverapamildonotenhancethesensitivityofhumanbonemarrowcfugmtoadriamycinandvp16 AT merrys clinicallyrelevantconcentrationsofverapamildonotenhancethesensitivityofhumanbonemarrowcfugmtoadriamycinandvp16 AT smithjg clinicallyrelevantconcentrationsofverapamildonotenhancethesensitivityofhumanbonemarrowcfugmtoadriamycinandvp16 AT kayesb clinicallyrelevantconcentrationsofverapamildonotenhancethesensitivityofhumanbonemarrowcfugmtoadriamycinandvp16 |